Previous 10 | Next 10 |
2023-05-04 02:33:01 ET Mirion Technologies, Inc. (MIR) Q1 2023 Earnings Conference Call May 3, 2023 12:00 ET Company Participants Alex Gaddy - Vice President, Finance Larry Kingsley - Chairman Tom Logan - Chief Executive Officer Brian Schopfer - Chief Financi...
2023-05-03 08:57:27 ET Mirion Technologies press release ( NYSE: MIR ): Q1 GAAP EPS of -$0.22. Revenue of $182.1M (+11.6% Y/Y) beats by $2.9M . For further details see: Mirion Technologies GAAP EPS of -$0.22, revenue of $182.1M beats by $2.9M
Revenues for the first quarter increased 11.6% to $182.1 million, compared to $163.2 million in the same period in 2022. Net loss was $42.9 million in the first quarter, compared to a net loss of $19.0 million in the same period last year. Adjusted EBITDA was $36.6 million, a 4.9% increas...
2023-05-02 12:42:57 ET Mirion Technologies ( NYSE: MIR ) is scheduled to announce Q1 earnings results on Wednesday, May 3rd, before market open. The consensus EPS Estimate is $0.05 (-50.0% Y/Y) and the consensus Revenue Estimate is $179.2M (+9.8% Y/Y). Over the last 1 ...
New Branding Initiatives Enhance Customer Engagement Mirion Technologies Has Rebranded to Mirion, Mirion Industrial is Now "Mirion Technologies" There is No Change in Mirion Medical Branding or Mirion’s Financial Reporting Methodology Mirion (“we” or...
Mirion Technologies, Inc. (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at Goldman Sachs’ Industrials & Materials Conference in New York, NY. The presentation will begin at 9:20 AM ET on Tuesday, May 9,...
Mirion Technologies, Inc. (NYSE: MIR) (“Mirion”) (“Company”) announced today that it will release its financial results for the first quarter of 2023 on Wednesday, May 3, 2023. Following the news release, the Company will host a conference call the same day at 12:00 pm...
HALIFAX, NS / ACCESSWIRE / April 3, 2023 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended January 31, 2023. Corporate Update Summary During the second financial quarter of 2023, MedMira continued its focus on its COVID-19 and Sexually Transmi...
Mirion Technologies ( NYSE: MIR ) priced an underwritten public offering of 9.79M shares by certain selling stockholders at $8.75M/share. Selling stockholders consist of entities affiliated with Charterhouse Capital Partners. The company will not sell any securities and w...
Mirion Technologies, Inc. (“Mirion,” “we” or the “company”) (NYSE: MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the pricing of an...
News, Short Squeeze, Breakout and More Instantly...
Mirion Technologies Inc. Class A Company Name:
MIR Stock Symbol:
NYSE Market:
Mirion Technologies Inc. Class A Website:
HALIFAX, NS / ACCESSWIRE / July 2, 2024 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended April 30, 2024. Corporate update In Q3 FY2024, MedMira focused on the launch of MedMira's latest US FDA approved Reveal ® G4 Rapid HIV 1/2 antibody...
2024-06-23 05:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-13 06:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...